Health Condition 1: F54- Psychological and behavioral factors associated with disorders or diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: children satisfying the DSM V criteria and having a CARS score above 30 after screening with M-CHAT and SCQ also Diagnosed cases of ASD
Exclusion criteria
Exclusion criteria: Children with intractable seizures and recurring upper respiratory infections will be excluded from the trial due to potential drug interactions and the possibility of an infection flare-up during the therapeutic phase Children having co-morbid conditions such as cerebral palsy, mental retardation and other chronic neurological and metabolic disorders will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the symptoms of patients in the following domains of ASD- sociability, speech and language, behavioral, sensory/cognitive.Timepoint: 45days | — |
Secondary
| Measure | Time frame |
|---|---|
| to assess the efficacy of trial medicines on diseaseTimepoint: 60 Days | — |
Countries
India
Contacts
Department of Kaumarbhritya, Government ayurvedic college and hospital, Kadamkuan, Patna.